Detalles de la búsqueda
1.
Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates.
PLoS Pathog
; 17(8): e1009736, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34432859
2.
Monoclonal Antibody 2C6 Targets a Cross-Clade Conformational Epitope in gp41 with Highly Active Antibody-Dependent Cell Cytotoxicity.
J Virol
; 93(17)2019 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31217246
3.
Primary antibody response after influenza virus infection is first dominated by low-mutated HA-stem antibodies followed by higher-mutated HA-head antibodies.
Front Immunol
; 13: 1026951, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36405682
4.
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions.
Front Immunol
; 13: 1091668, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36483568
5.
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions.
Front Immunol
; 13: 893648, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35651621
6.
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protection.
Cell Host Microbe
; 30(12): 1759-1772.e12, 2022 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36400021
7.
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.
Science
; 369(6504): 643-650, 2020 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32540902
8.
Natural infection as a blueprint for rational HIV vaccine design.
Hum Vaccin Immunother
; 13(1): 229-236, 2017 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27649455
Resultados
1 -
8
de 8
1
Próxima >
>>